Key Highlights

  • Lucas GC (NASDAQ:LGCL) traded at USD 1.56, up 9.86%, in pre-market trading on Tuesday, October 27, 2026, with no company-specific announcement that day. A 125-for-1 share consolidation took effect on Tuesday, September 1, 2026.
  • Farmmi (NASDAQ:FAMI) traded at USD 0.1120, up 8.42%, with no dated announcement. An offering priced at USD 0.25 per share on Monday, June 29, 2026 sits far above the quote, and a Nasdaq bid notice runs to Monday, February 8, 2027.
  • Origin Agritech (NASDAQ:SEED) traded at USD 0.8519, up 7.84%, after the company's release of Monday, October 26, 2026 on corn varieties, the only dated same-week catalyst among the four.
  • Haoxi Health Technology (NASDAQ:HAO) traded at USD 1.70, down 13.27%, the only decline of the four. Two reverse splits and two direct offerings in 2026 frame the move. All quotes are thin snapshots.

Lucas GC (NASDAQ:LGCL): consolidation meets a margin gain

Lucas GC (NASDAQ:LGCL), a Beijing-based company that runs an artificial intelligence platform-as-a-service business for the human resources and insurance industries, reported interim results in its release of Wednesday, October 7, 2026, in Renminbi with United States dollar convenience translations. Revenue fell 36.6% year over year to RMB 245.3 million, and gross profit fell 33.4% to RMB 86.9 million, although gross margin rose to 35.4% from 33.7%. Operating income rose 69.1% to RMB 25.9 million, net income fell 7.6% to RMB 19.9 million and operating cash flow rose 91.9% to RMB 8.3 million. Cash and equivalents were RMB 10.4 million at Tuesday, June 30, 2026.

The consolidation reduced the share count, and market data indicate a very small free float. Simple arithmetic on the snapshot implies a prior close of about USD 1.42, and the gain appears consistent with thin liquidity, which is an inference. The bull reading rests on the higher margin, the rise in operating income and patents received in June 2026 for agentic artificial intelligence processes. The bear reading rests on the revenue decline and a modest cash balance. The at-the-market programme of USD 20 million with Maxim Group was terminated on Thursday, July 2, 2026 without sales. Listing compliance remains a risk, as the shares received a Nasdaq minimum bid price notice in September 2025.

Farmmi (NASDAQ:FAMI): a bid-price notice and a share-funded deal

Farmmi, Inc. (NASDAQ:FAMI), a Cayman Islands holding company whose operating subsidiaries are based in mainland China and which has historically focused on edible fungi products, filed its annual report on Form 20-F, accepted by the SEC on Tuesday, February 10, 2026, for the year ended September 30, 2025. Revenue was USD 27,971,360, against USD 64,131,332 in fiscal 2024, and the net loss was USD 53,385,988. Shareholders' equity was USD 123,857,452. The June offering covered 12,000,000 Class A shares and pre-funded warrants, raising about USD 3.0 million gross, and on Tuesday, August 4, 2026 the company signed a framework agreement to acquire 100% of FOUR SEASONS HOLDING GROUP BRAZIL LTDA, payable in Class A shares.

Dilution here is both realised and prospective. The quote is about 55% below the offering price, by simple arithmetic, and market capitalisation is about USD 4.2 million according to market data, so the rise appears consistent with thin liquidity, an inference. The bull reading is that the equity base, if realisable, far exceeds market value. The bear reading is that revenue more than halved. The Nasdaq notice of Tuesday, August 11, 2026 follows 30 consecutive business days of closes below USD 1.00 under Listing Rule 5550(a)(2), and compliance needs 10 consecutive business days at or above USD 1.00.

Origin Agritech (NASDAQ:SEED): approvals and pre-orders against placements

Origin Agritech Limited (NASDAQ:SEED), a China-based agricultural biotechnology company that breeds and sells corn seed, issued a release on Monday, October 26, 2026 stating that three corn varieties, Aoxiangyu 819, Aoyu 966 and Aoyu 288, passed China's preliminary national review and advance toward commercialisation in the Huang-Huai-Hai region. Two-year regional trial yields exceeded controls by 8.6%, 6.9% and 6.0%. The link between that release and the price is an inference. A shareholder letter of Wednesday, October 21, 2026 stated that fiscal 2027 seed pre-orders and customer advance payments are each up more than 100% year to date and that the company targets revenue growth above 50%.

The company reported a net loss narrowing by 44% in its first-half fiscal 2026 release; absolute figures are not quoted here. Funding comes from private placements, including 2,000,000 shares at USD 1.40 for USD 2.8 million, received in full on Tuesday, October 13, 2026. That price is above the current quote, by simple arithmetic. Preliminary review is not final approval, and a public notice period runs from Thursday, October 22 to Sunday, November 22, 2026. The company's October 2026 releases do not refer to a Nasdaq listing notice, although a price below USD 1.00 leaves bid-price compliance a latent risk.

Haoxi Health Technology (NASDAQ:HAO): two splits and a loss

Haoxi Health Technology (NASDAQ:HAO), a China-based company that provides digital marketing and livestreaming services, filed its annual report on Form 20-F on Wednesday, September 30, 2026 for the year ended June 30, 2026. Revenue was about USD 54.83 million, up 67.1%, and the company reported a net loss of about USD 9.54 million against net income of about USD 3.9 million a year earlier. Cash was about USD 11 million, against about USD 8.6 million. Figures are rounded, and the currency is taken to be USD. The most recent company release is dated Wednesday, August 12, 2026 and announced a 1-for-20 reverse share split, which reduced Class A ordinary shares from 11,904,632 to about 595,232.

The financing record explains the pressure. A registered direct offering announced on Monday, May 11, 2026 raised USD 6.5 million at USD 0.25 per share, and a second, on Friday, July 10, 2026, raised USD 4 million at USD 0.40 per share, both before the splits. The decline appears consistent with thin liquidity and with that dilution pattern, an inference. The bull reading is revenue growth and higher cash for artificial intelligence marketing frameworks with NOVA MEDIA and Eaglepoint AI, and the bear reading is the move from profit to loss. Renewed Nasdaq minimum bid price non-compliance, which applies below USD 1.00, is a risk if the price falls again.

Where Things Stand

The answer is that dilution weighs on all four names, but through different channels. Lucas GC (NASDAQ:LGCL) carries a consolidation and a thin float while operating income improves. Farmmi (NASDAQ:FAMI) combines an uncured bid-price deficiency with share-funded acquisition terms. Origin Agritech (NASDAQ:SEED) has a dated product catalyst that private placements partly offset. Haoxi Health Technology (NASDAQ:HAO) shows the heaviest record of splits and offerings and was the only name to fall.

The next catalysts are the Federal Reserve decision on Wednesday, October 28, 2026, which follows the rate rise to 4.00% from 3.75% on Wednesday, September 16, 2026 and the end of the public notice period on Sunday, November 22, 2026. Pre-market prices are snapshots and can change, and this is not investment advice.